淀粉样蛋白PET诊断散发性脑淀粉样血管病的诊断准确性荟萃分析
该荟萃分析纳入7项病例对照研究(106例CAA患者,151例对照),评估淀粉样蛋白PET诊断散发性CAA的准确性。汇总敏感度为79%(95%CI 62-89),特异度为78%(95%CI 67-86);在脑叶出血CAA亚组中敏感度79%(95%CI 61-90),特异度84%(95%CI 65-93)。淀粉样蛋白PET对 probable CAA 与健康对照或深部ICH的鉴别具有中等至良好诊断准确性。
要点
- 淀粉样蛋白PET诊断CAA的汇总敏感度79%、特异度78%。
- 脑叶出血CAA亚组敏感度79%、特异度84%。
- 18F-florbetapir PET诊断CAA-ICH敏感度90%、特异度88%。
核心结论
- 淀粉样蛋白PET在区分 probable CAA 与认知正常健康对照或深部ICH患者方面具有中等至良好的诊断准确性。
研究设计与样本
- PubMed系统文献检索纳入7项病例对照研究,包括106例CAA患者(>90%为probable CAA)和151例对照。
- 采用分层(多水平)逻辑回归模型计算汇总诊断试验准确性。
主要发现
- 淀粉样蛋白PET诊断CAA的敏感度范围为60%至91%,特异度范围为56%至90%。
- 汇总敏感度为79%(95%CI 62-89),汇总特异度为78%(95%CI 67-86)。
- 脑叶ICH CAA亚组(58例 vs 86例对照)敏感度79%(95%CI 61-90%),特异度84%(95%CI 65-93%)。
- 2项使用18F-florbetapir-PET的研究双变量诊断准确性荟萃分析显示,CAA-ICH诊断敏感度90%(95%CI 76-100%),特异度88%(95%CI 74-100%)。
关键数值与推荐
- 研究质量中等至高等,但在PET阳性和阴性定义及相关截断值等方法学方面存在差异。
临床怎么用
- 淀粉样蛋白PET可辅助鉴别probable CAA与认知正常健康对照或深部ICH患者。
- 鉴于淀粉样蛋白PET同时标记脑血管和脑实质淀粉样蛋白,在适当临床情境下阴性扫描可能有助于排除CAA。
局限性
- 纳入研究在PET阳性和阴性病例定义及相关截断值等方法学方面存在差异。
- 样本量有限(7项研究,106例CAA患者和151例对照)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To perform a meta-analysis synthesizing evidence of the value and accuracy of amyloid-PET in diagnosing patients with sporadic cerebral amyloid angiopathy (CAA). METHODS: In a PubMed systematic literature search, we identified all case-control studies with extractable data relevant for the sensitivity and specificity of amyloid-PET positivity in symptomatic patients with CAA (cases) vs healthy participants or patients with spontaneous deep intracerebral hemorrhage (ICH) (control groups). Using a hierarchical (multilevel) logistic regression model, we calculated pooled diagnostic test accuracy. RESULTS: Seven studies, including 106 patients with CAA (>90% with probable CAA) and 151 controls, were eligible and included in the meta-analysis. The studies were of moderate to high quality and varied in several methodological aspects, including definition of PET-positive and PET-negative cases and relevant cutoffs. The sensitivity of amyloid-PET for CAA diagnosis ranged from 60% to 91% and the specificity from 56% to 90%. The overall pooled sensitivity was 79% (95% confidence interval [CI] 62-89) and specificity was 78% (95% CI 67-86) for CAA diagnosis. A predefined subgroup analysis of studies restricted to symptomatic patients presenting with lobar ICH CAA (n = 58 vs 86 controls) resulted in 79% sensitivity (95% CI 61-90%) and 84% specificity (95% CI 65-93%). In prespecified bivariate diagnostic accuracy meta-analysis of 2 studies using 18F-florbetapir-PET, the sensitivity for CAA-ICH diagnosis was 90% (95% CI 76-100%) and specificity was 88% (95% CI 74-100%). CONCLUSIONS: Amyloid-PET appears to have moderate to good diagnostic accuracy in differentiating patients with probable CAA from cognitively normal healthy controls or patients with deep ICH. Given that amyloid-PET labels both cerebrovascular and parenchymal amyloid, a negative scan might be useful to rule out CAA in the appropriate clinical setting.
引用
- Charidimou A, Farid K, Baron JC, et al. Amyloid-PET in sporadic cerebral amyloid angiopathy: A diagnostic accuracy meta-analysis. Neurology. 2017. PMID: 28855406. doi:10.1212/WNL.0000000000004539
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。